Simultaneous Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) scanning is a recent major development in biomedical imaging. The full integration of the PET detector ring and electronics within the MR system has been a technologically challenging design to develop but provides capacity for simultaneous imaging and the potential for new diagnostic and research capability. This article reviews state-of-the-art MR-PET hardware and software, and discusses future developments focusing on neuroimaging methodologies for MR-PET scanning. We particularly focus on the methodologies that lead to an improved synergy between MRI and PET, including optimal data acquisition, PET attenuation and motion correction, and joint image reconstruction and processing methods based on the underlying complementary and mutual information. We further review the current and potential future applications of simultaneous MR-PET in both systems neuroscience and clinical neuroimaging research. We demonstrate a simultaneous data acquisition protocol to highlight new applications of MR-PET neuroimaging research studies. capturing even very small changes in brain structure and function. PET is highly specific in measuring numerous molecular targets in the brain including glucose metabolism, oxygen usage and neurotransmitter distribution and concentration. Although PET provides unmatched ability to image numerous biochemical and molecular targets, its ability to capture detailed spatial and anatomical information is limited. Thus, the integration of two modalities in a simultaneous MR-PET system, also referred as PET/MR, offers a unique opportunity for multidimensional neuroimaging (Judenhofer et al., 2008) . In this article, we review the current state-of-play of simultaneous MR-PET imaging, with a particular focus on applications in neuroimaging and cognitive neuroscience.
| INTRODUCTION
Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) are widely used in vivo imaging modalities that provide complementary information about the brain. MRI has excellent sensitivity in capturing even very small changes in brain structure and function. PET is highly specific in measuring numerous molecular targets in the brain including glucose metabolism, oxygen usage and neurotransmitter distribution and concentration. Although PET provides unmatched ability to image numerous biochemical and molecular targets, its ability to capture detailed spatial and anatomical information is limited. Thus, the integration of two modalities in a simultaneous MR-PET system, also referred as PET/MR, offers a unique opportunity for multidimensional neuroimaging (Judenhofer et al., 2008) . In this article, we review the current state-of-play of simultaneous MR-PET imaging, with a particular focus on applications in neuroimaging and cognitive neuroscience.
Although the idea of an integrated MR-PET scanner arose more than 25-year ago, physical integration of the two systems has proven to be a difficult task (Herzog & Lerche, 2016) . The mutual interference of MR and PET technologies represented a major technical challenge for the development of hybrid systems and required several generations of technology development. The first generation of simultaneous MR-PET scanners that were developed utilised an MR compatible PET detector insert with PET technology sized to fit within the bore of a standard MRI scanner. The success of this approach led to further developments of MR-compatible PET detector technology (see Section 2.1). While the insert technology does provide simultaneous acquisition of MR and PET images, the reduced MR scanner bore size severely limits the size of the sample (i.e., the patient, specific body parts) that can be scanned using this architecture. Nevertheless, the smaller effective MR bore size with the PET insert results in higher PET sensitivity and image spatial resolution than for fully integrated systems. Fully integrated systems that place the PET detector ring and electronics within the MR system have been the most technologically challenging designs to develop but provide capacity for simultaneous whole-body imaging and the potential for new diagnostic and research capability (Delso & Ziegler, 2009 ). Integrated system architecture was long the 'holy grail' of MR-PET technology and with the development of novel PET detector technologies, commercial systems are now available. Although the current generation of hardware is now capable of providing simultaneously acquired MR and PET data sets, the development of integrated data processing and analyses is currently an area of active research. Much research is now focused on developing processing pipelines that lead to an improved synergy of the two data sets, including optimal data acquisition and joint post-processing methods for both modalities, and novel applications based on the underlying complementary and mutual information.
From the perspective of applications in neuroimaging, simultaneous MR-PET can be useful in many situations. Brain PET is unrivalled in the neuroimaging field for the quantification of molecular targets, and so the combination of PET data with MR greatly expands the physiological targets that can be examined by neuroscientists. For example, in fundamental neuroscience, the dual modality system can be used to understand the inter-relationship between cerebral glucose metabolism and BOLD-fMRI activity (Wehrl et al., 2013) . In cognitive neuroscience, simultaneous MR-PET can be used to understand the neurochemical bases of cognition, human brain development and agerelated degeneration and disease states (Jones, Rabiner, & PET Research Advisory Company, 2012) . In clinical neuroimaging, simultaneous MR-PET using [18-F] PET imaging can be used to elucidate the metabolic status of a tumour including transportation of amino acids, cellular proliferation and tissue hypoxia (Catana, Drzezga, Heiss, & Rosen, 2012) . With the simultaneous MR-PET system, more effective staging and monitoring of diseases can be achieved by combining the diagnostic features of both MR and PET.
In the current literature, several papers provide excellent overviews of the state-of-the-art of MR-PET instrumentation (Herzog & Lerche, 2016; Vandenberghe & Marsden, 2015) , comparison of existing attenuation correction methods (Ladefoged et al., 2017) , review of motion correction strategies in whole body MR-PET (Furst et al., 2015) , as well as an overview of neurologic applications (Catana et al., 2012) and whole body oncological applications (Antoch & Bockisch, 2009) . In this review, we comprehensively review the challenges and opportunities in simultaneous MR-PET instrumentation, data acquisition and processing with a particular focus on neuroimaging and its applications in systems neuroscience and clinical neurosciences. Using a simultaneous functional MRI-functional FDG-PET example, we will highlight the unique opportunities that MR-PET now provide for neuroimaging research applications.
| SIMULTANEOUS MR-PET SYSTEM DESIGN
A PET scanner detects annihilation photons via a scintillating crystal that creates a burst of light that is detected by photon detectors (Bailey, 2005 ). An MRI system operates in an elegant interaction of a strong static magnetic field, a spatially varying magnetic field and a radio frequency (RF) produced magnetic field. Thus, inclusion of a PET detector inside the MRI bore can affect the operation of both MRI and PET subsystems: the high static magnetic field and switching gradients can interfere with the electronics of the PET detectors, and the presence of the PET detector causes field inhomogeneities, eddy currents and electromagnetic interference to the MR system (Vandenberghe & Marsden, 2015) . However, studies suggest that it is possible to obtain MR and PET images with limited artefacts using a simultaneous system (Delso et al., 2011; Grant et al., 2016) . This section reviews the major design considerations for a simultaneous MR-PET system for imaging the brain, focusing first on the development of novel PET detectors suitable for the MR environment, then examining the effects of PET detector technology on the MR system.
| MR compatible PET detectors
It is a nontrivial task to develop PET detectors that can operate inside an MR system without interference to the signal generation and detection of both modalities. The initial hurdle of hybrid MR-PET scanner design was the separation of photomultiplier tubes (PMTs) and scintillators, as PMTs cannot operate within the strong magnetic field. As such, early efforts to develop a hybrid system focused on transporting the scintillation light from scintillator crystals inside the MR scanner to PMTs located outside the main magnetic field via optical fibres (Shao et al., 1997) .
Unlike PMTs, avalanche photodiodes (APDs) have low gains and are more sensitive to temperature changes, but can operate inside a strong magnetic field and this has been shown up to 9.4 T. Thus, the second generation of hybrid systems used APD PET detectors inserted into the MR magnet bore (Catana et al., 2006; Grazioso et al., 2006; Judenhofer et al., 2008; Woody et al., 2007) . Insert designs resulted in MR signal to noise ratio decreases of 15%, and APD PET detector sensitivity decline of approximately 5-20%; however, images were obtained without significant artefact or distortion (Grazioso et al., 2006) . Furthermore, the insert design is complex to setup and operate. These image quality and workflow issues led to the development of fully integrated MR-PET systems which integrated the PET detector between the MR scanner gradient and the RF coils.
Using a Siemens Biograph mMR, Delso et al. (2011) (Otte et al., 2005) . The improved timing resolution enables time-of-flight (TOF) imaging in MR-PET, which can improve image quality in large field of view (e.g., whole-body PET). However, compared with PMT, both APD and SiPM are more sensitive to temperature changes (Table 2 in Spanoudaki & Levin, 2010) , and a sophisticated cooling design is therefore necessary in the MR-PET scanner.
Another recent development in PET detector technology is the development of digital SiPMs, in which SiPMs are fabricated into microcell arrays with the signals from each microcell summed digitally.
A fully digital SiPM (dSiPM) can potentially offer excellent spatial and temporal resolution. These characteristics make dSiPM a desirable solution for simultaneous MR-PET imaging. However, as a prototype technology, it has been demonstrated that dSiPMs tend to generate electromagnetic noise, potentially degrading MR image quality (Weissler et al., 2015) . dSiPMs are also potentially affected by gradient switching in the MR subsystem (Wehner et al., 2014) . Thus, further work is required to develop dSiPM technology for reliable and noise free applications in simultaneous MR-PET imaging. Table 1 summarises the basic performance characteristics of different PET detector technologies (Hergert, 2016) . One important motivation behind the development of new photodetector technologies for MR-PET is improvement in spatial and temporal resolution.
While there is an inherent physical limit to the spatial resolution in PET, the intrinsic resolution of the technology is also closely related to the PET detector gamma ray positioning accuracy, and the distance between coincident detectors (Lecomte, 2009) . Current state-of-theart MR-PET scanners offer a~4 mm isotropic PET resolution for imaging the brain (even though most clinical images are reconstructed with 1.5-3 mm isotropic voxel size for MR-PET brain imaging) (Delso et al., 2011) , while anatomical 3 T MR can easily achieve~1 mm isotropic resolution.
| MR static magnetic field and gradient components
Much research into the issue of between-modality interference has focused on the effects of MR on PET, with the general consensus that the effect of MR on PET can be minimised as long as the PET detector and read-out electronics are properly shielded (Wehrl et al., 2011) . On the other hand, the effect of PET on MR is a more complex issue to examine, as the effects are likely to differ according to the MR imaging sequences that may generate differential susceptibility artefacts and RF interference (Vandenberghe & Marsden, 2015; Wehrl et al., 2011) . The physical presence of the PET scanner components within the magnet bore can affect the homogeneity of the static magnetic (B 0 ) field and degrade the linearity of the MR gradients, due to the magnetic susceptibility of the PET detectors and their associated shielding electronics. Therefore, only MR compatible PET detectors can be used, and the static B 0 field must be recalibrated when the PET detectors are fully integrated into the MR magnet bore. Furthermore, to avoid operating frequency interference, filters must be placed between the MR gradient and radiofrequency components and the PET detector electronics.
Spatial and temporal stability of the integrated system are critical factors, especially for functional MRI (fMRI) and dynamic PET imaging in neuroimaging experiments. Because of the confined area in which the PET detectors are positioned within the MR system, the PET components must be isolated from the gradient coil. Advanced functional and diffusion MRI of the brain requires rapid gradient switching, running under full duty cycle over long-time periods. The rapidly switching magnetic fields can induce eddy current loops in any conductive components in the PET circuitry. In addition, the gradient switching may increase the temperature of components, which can induce significant drifts in the gain of solid-state photodetectors such as APDs and SiPMs. These effects degrade the energy resolution of PET detectors, cause sensitivity variations and result in errors when quantifying the PET images (Espana et al., 2010) . Lastly, fast switching of gradients causes mechanical vibrations of the coils which can compromise the robustness and lead to a reduced lifespan of the PET detectors and electronics. Thus, to ensure image quality and stability of the PET data, the PET detector rings placed inside the gradient coils must be physically well separated from the coils.
| RF components and hardware attenuation
The MR receive pathways are highly sensitive and shielded within a Faraday cage to detect the very small nuclear magnetic resonance (NMR) signals in tissue, and to minimise frequency interference. Integration of PET and the MR RF components requires special consideration to avoid crosstalk between the operating frequencies in both systems. For example, RF interference to PET front-end electronics may cause an increase in PET random count rates, triple coincidence count rates and dead time problems (Delso & Ziegler, 2009 potential utilisation of build-in body coil for MR imaging (Grant, Lee, Chang, & Levin, 2017) . In general, integration of the two components requires additional shielding which must be carefully considered, as the shielding itself may degrade the uniformity of the static B 0 magnetic field or interact with the gradients of the scanner (Truhn, Kiessling, & Schulz, 2011 (Sander et al., 2015) .
| MR-PET DATA ACQUISITION AND IMAGE RECONSTRUCTION
The integrated MR-PET scanner enables acquisition of information from both modalities simultaneously. This, however, adds complexity in data acquisition, correction and image reconstruction. In a clinical setting, most of the imaging workflow needs to be completed within an hour to be cost-effective. However, in research settings such workflow time constraints are a less important issue. Figure 1 shows an overview of data flow during a simultaneous MR-PET imaging experiment and highlights the unique modules associated with the dual modality system. A detailed review on patient centric workflow consideration in MR-PET imaging can be found in (von Schulthess & Veit-Haibach, 2014 ). Here, we will focus on technical aspects of the data acquisition and reconstruction.
| MR-PET data acquisition strategies for brain imaging
Protocol optimisation requires careful consideration of the anatomy of interest and specific imaging target (e.g., tumours, glucose metabolism, etc. 
| Attenuation correction (AC) in MR-PET
In order to obtain quantitative PET images, it is necessary to correct the PET data for photon attenuation and scatter [for a review see Juttukonda et al., 2015; Keereman et al., 2010; Ladefoged, Benoit, Law, Holm, Kjaer, et al., 2015 Huang et al., 2015; Wiesinger et al., 2016) . In contrast to UTE, ZTE is a proton density-based method, which enables gradients during RF, resulting in a nominal echo time of 0. The proton density image is then used to obtain attenuation coefficients of air cavities, bone and soft tissue.
| Atlas and template based AC
Typically, an atlas consists of pairs of anatomical MR images (or an MR template) and the corresponding CT images (or an AC template).
The acquired MR anatomical images (e.g., T1-weighted images) are co-registered with the MR atlas/template using nonrigid registration methods or probabilistic methods, and the same transformation is applied to the atlas CT images to obtain a subject-specific AC map (Wagenknecht et al., 2013) . Schreibmann et al. proposed a multimodality optical flow deformable model where AC maps are created by deforming a standard CT template to match the subject's MR anatomical images (Schreibmann et al., 2010) . This method provided geometric accuracy with less than 3 mm discrepancy between the MR-based method and the CT-based method for bone and skin. Pseudo-CT methods (Burgos, Cardoso, Thielemans, Modat, 2014; Hofmann et al., 2008; Koesters et al., 2016) register the atlas/template images into the subject's MR image. The resultant deformation is then used to warp the atlas CT into the subject space. Pseudo-CT AC is obtained by combination of all the atlas CT images. Roy et al. proposed a patch matching method to synthesise the AC map from dual-echo UTE images and CT images (Roy et al., 2014) . The combination of the matched patches is done using a Bayesian framework and no explicit registration is needed. This method provides AC maps that have an excellent correlation (0.99) with CT-based AC maps. Izquierdo-Garcia et al. proposed a segmentation and template method based on SPM8 (Statistical Parametric Mapping 8) software . To obtain an MR-CT template, MR images were first segmented into six tissue classes, and then nonrigidly co-registered these tissue classes to form a template space.
Finally, CT images were transformed into the template space, and the AC template was generated by averaging all transformed CT images. This method resulted in reconstructed PET images having less than 4% mean relative errors compared to the CT based approach.
| PET-based AC
In the early PET only systems that included germanium-68 rod sources, attenuation information could be estimated from the PET 
| Methods comparison and validation
Attenuation correction is a priority area for development in MR-PET, as noncorrected images show substantial spatially variant artefacts across the brain, and significant [up to 25%; (Andersen et al., 2014)] underestimation of radiotracer uptake. A comparison of the advantages and disadvantages of each AC method category is presented in recently showed that a continuous LAC UTEbased approach showed more accurate bone attenuation and lower overall reconstruction error, compared to a fixed LAC UTE-based approach. For atlas-based methods, the correction accuracy critically depends on the accuracy of the atlas itself, and different demographic and disease groups require different atlases to minimise bias. For example, the density of the cortical bone changes significantly across the adult lifespan, with different trajectories for males and females (Thompson, 1980) . Furthermore, atlas-based methods need to account for inter-individual variability to achieve high accuracy and are computationally demanding, which limits their application in the clinical environment.
Recently, machine learning methods have been developed to generate pseudo-CT AC maps (Leynes et al., 2018; Liu, Jang, Kijowski, Bradshaw, & McMillan, 2018 reported for the atlas-based methods (Burgos, Cardoso, Thielemans, Modat, 2014; Izquierdo-Garcia et al., 2014; Merida, Costes, Heckemann, & Hammers, 2015) and for the segmentation-based method . Note although these studies are comprehensive, the use of CT-AC as the gold standard for validating PET reconstructions from MR-PET data sets is debatable. There may be registration errors between the CT and MR images, and there are differences between PET and CT in photon detection energy (Burger et al., 2002) . Therefore, further clinical evaluation of various attenuation correction methods is still needed.
| Head motion correction in the simultaneous MR-PET
During an imaging session subject motion can lead to degradation of the acquired images and the occurrence of false positives in the 3.3.1 | Prospective motion correction using external hardware
External cameras or sensors can be used to track head motion and communicate motion parameters to the imaging system for prospective motion correction. Measuring motion and updating the imaging acquisition protocol in real time is very useful for MR imaging, but it is somewhat less critical for PET due to lower image resolution, and it is unnecessary to update PET detector geometry for prospective motion correction due to its symmetrical layout. The mathematical basis of prospective motion correction for any imaging modality relies upon the maintenance of a constant relationship between the imaged object and the image itself, even under motion (Maclaren, Herbst, Speck, & Zaitsev, 2013) . For example, Picard and Thompson (1997) use two CCD cameras together with three LEDs fixed on the subject's head to monitor head movement for PET imaging. Maclaren et al. (2013) argued that a number of challenges must still be addressed before prospective motion correction routines can be widely implemented, including data quality issues, the choice of a motion tracking marker and its position on a subject, and the inability to correct for higher-order motion and static B 0 magnetic field inhomogeneities introduced by the movement itself. Another practical issue with the use of external hardware-based motion correction technologies is the complexity of integrating them into either MRI or PET, with their incorporation into dual modality systems being even more challenging. Last but not least, patient compliance also need to be addressed for routine usage of hardware-based approaches.
| PET data driven motion correction methods
The relatively poor spatial resolution of traditional PET scanners has meant that the technique was previously considered relatively robust against subject movement. However, with the increased spatial resolution provided by the current generation of PET detectors, even small motion can degrade PET image quality. Most PET data driven methods have been developed mostly to correct for respiratory and cardiac motion in whole-body PET (Catana, 2015; Furst et al., 2015) , but some of the recent work has introduced motion correction for brain studies. Thielemans, Schleyer, Dunn, Marsden, and Manjeshwar (2013) Another approach to derive motion parameters is to rigidly coregister the reconstructed PET images. To achieve fine motion modelling, it is desirable to have shorter temporal PET frames (i.e., higher temporal resolution). However, there is always a tradeoff between signal to noise (SNR) and temporal resolution. Mukherjee et al. (2016) proposed a pre-processing pipeline to achieve high registration accuracy with short frames (e.g., 5 s). These processing steps combine Gaussian smoothing for noise reduction, median filtering for edges preservation and Gamma contrast enhancement for each short temporal frame. This approach is promising for retrospective motion correction of nonattenuation corrected PET brain images.
| MR-informed motion correction
MR informed motion correction can be superior compared to PET data driven methods, especially at low dose PET experiments or dynamic PET image reconstruction, due to high SNR and anatomical accuracy in MR images [Furst et al. (2015) demonstrated this in whole-body applications]. A simple approach to MR informed motion correction for the brain is to perform a rigid-body coregistration of MRI EPI volumetric images that can be acquired periodically throughout a hybrid imaging protocol. The derived motion parameters can then be used to correct motion in the PET data acquisition by either realignment of PET frames (Catana et al., 2011; Keller et al., 2015; Ullisch et al., 2012) or by directly correcting the raw list mode PET data prior to reconstruction (Ullisch et al., 2012) . This simple approach is complicated by the fact that simultaneously acquired MRI and PET data may be spatially misregistered, as the centre of the PET FOV may not fall within the isocentre of the MR scanner (Catana et al., 2011) . In this case, an additional transformation matrix must be obtained by scanning a phantom visible to both modalities for application during the motion correction routine. This calibration matrix together with other post-processing steps such as EPI distortion correction are needed to achieve accurate motion correction. Another issue with this approach is that EPI scans cannot be used to track motion during anatomical MR acquisitions such as T1 or T2 and inserting multiple EPIs into the MR protocol lengthens the total acquisition time unless used in EPI based protocols, for example, BOLD fMRI.
MR navigators are also widely used to track head motion in order to achieve prospective motion correction. (Engstrom et al., 2015) , vNav EPI navigators (Tisdall et al., 2016) , PROMO which is a 3D spiral navigator (White et al., 2010) , k-space orbital navigators (Fu et al., 1995) and k-space spherical navigators (Johnson, Liu, Wade, Tavallaei, & Drangova, 2016; Welch, Manduca, Grimm, Ward, & Jack, 2002) .
Another technique used for fMRI prospective motion correction is the Prospective Acquisition CorrEction (PACE) method (Thesen, Heid, Mueller, & Schad, 2000) . This method estimates motion matrices between two consecutive fMRI volumes and then applies motion adjustments in real time for the subsequent scans. In comparison to EPI volumes, MR navigators in general provide faster motion sampling (e.g., in every TR of milliseconds to seconds range) and have minimal impact on total acquisition and processing time.
However, many of these navigators are not available in the vendor provided sequences due to their complexity in implementation and validation.
Each of the approaches discussed so far have a number of advantages and disadvantages (summarised in Table 3 
| Recent developments in MR-PET image reconstruction 3.4.1 | Joint MR-PET image reconstruction
The goal of synergistic joint MR-PET image reconstruction is to improve the image quality of both modalities, such as reduction of MR image artefacts and reduction of PET partial volume effects.
Essentially, the optimization problem of joint MR-PET image reconstruction can be written as (Ehrhardt et al., 2015; Knoll et al., 2016; Mehranian et al., 2018; Sudarshan, Chen, & Awate, 2018) : 
| NEW OPPORTUNITIES USING SIMULTANEOUS MR-PET IN BRAIN IMAGING

| Neuroimaging in neuroscience
In this section, we will review some of the major developments in the use of simultaneous MR-PET imaging in neuroscience. Most research in this area has been focused towards using PET to understand the neurovascular coupling that underlies the BOLD response. fMRI relies on the haemodynamic BOLD response, which is a composite of all neurochemical events in response to neuronal activity. In contrast,
PET provides neurochemical mapping of multiple processes including synthesis, reuptake and release, with high specificity. Thus, simultaneous MR-PET offers great potential for disentangling neurochemical contributors to the haemodynamic response. We will also review studies that have used metabolic or receptor imaging to understand the molecular components of brain function, and how MR-PET can be incorporated with EEG for advanced neuroscience studies.
| Utility of simultaneous MR-PET in neuroscience
The goal of biomedical imaging technologies in neuroscience is to (Table 4 provides a selective list of radiotracers used in neuroscience research to date).
Of course, it has always been possible to acquire both PET and MRI data in the same individuals, and PET neuroimaging studies usually acquire MRI scans to provide the anatomical information required to interpret low spatial resolution PET images. For example, many studies implement the same experimental protocol across two separate scanning sessions using independent MR and PET scanners.
However, nonsimultaneous MR-PET acquisition provides a number of advantages over sequential acquisitions in neuroscience. Firstly, sequential acquisitions that occur hours, days or weeks apart result in significant intra-individual differences in attention, motivation, sleep status, caffeine and nutritional intake and blood chemistry. This is especially problematic for some cognitive paradigms such as memory and learning tasks that are simply unable to be repeated across testing sessions without learning effects. It is therefore very difficult to control for all experimental confounds when comparing an individual's performance and brain activity between imaging sessions. Secondly, some subject groups such as patients with dementia or advanced neurodegenerative disorders resulting in ataxia or Parkinsonism, may be incapable of withstanding multiple imaging sessions of an hour or more. Simultaneous acquisition of PET and MR data effectively halves the total imaging time for a single subject. Thirdly, mis-registration of images between modalities becomes a significant issue in nonsimultaneous acquisitions, due to inter-session differences in subject placement. Many of these issues can be eliminated using integrated scanners that provide nonsimultaneous imaging, where MR and PET acquisitions can be interleaved within a scanning session, eliminating the between-session differences in participant state (fatigue, motivation) and subject positioning. However, integrated nonsimultaneous Ehrin et al. (1985) D2/D3 receptor antagonist [11-C]FLB457 Halldin et al. (1995) [18-F]fallypride Mukherjee et al. (1999) [18-F]desmethoxyfallypride Dobrossy et al. (2012) Transporter (reuptake inhibitors) [11-C]nomifensine Aquilonius et al. (1987) [11-C]β-CIT-FE Halldin et al. (1996) [11-C]altropane Elmaleh et al. (1996) [11-C]d-threo-MP Ding et al. (1995) [ Lemaire, Cantineau, Guillaume, Plenevaux, and Christiaens (1991) [18-F]setoperone Blin, Pappata, Kiyosawa, Crouzel, and Baron (1988) [11-C]NMSP Lyon et al. (1986) [11-C]volinanserin Schmidt, Fadayel, Sullivan, and Taylor (1992) 5HT-4 receptor antagonist 
acquisitions cannot match the temporal dynamics of brain function between MR and PET as is possible using simultaneous acquisitions.
| Simultaneous BOLD-fMRI/FDG-PET imaging
A number of studies have used simultaneous MR-PET to quantify brain activity via cerebral glucose metabolism using [18-F]FDG PET.
The use of glucose metabolism as a direct, quantifiable and metabolically well understood measure of neuronal activity is superior to the use of the blood oxygenation level dependent (BOLD) measure used in fMRI (for a review see (Mergenthaler, Lindauer, Dienel, & Meisel, 2013) . Simultaneous FDG-PET/BOLD-fMRI offers the opportunity to develop improved models of the physiological processes that underlie the BOLD fMRI signal (Wehrl et al., 2013) . Most glucose metabolism in the brain occurs at the synapses (Harris, Jolivet, & Attwell, 2012) , and the regional cerebral metabolic rate of glucose metabolism (rCMRGlc) increases linearly with spike frequency (Sokoloff, 1999) .
While the BOLD-fMRI signal is more heavily weighted towards the draining veins and macrovessels, the FDG-PET signal arises primarily from excitatory synaptic activity, which is localised to the grey matter tissue compartment, with a relatively low signal in white matter and blood (Wehrl et al., 2013) . As a result of these differences, compari- Other projects have focused on improving the temporal resolution of FDG-PET. Standard FDG-PET imaging in human neuroscience research uses the bolus administration method, where an FDG dose is administered to the participant s a bolus injection, which is then followed by~30mins quiet rest for the glucose uptake. Following the uptake period, the subject is positioned in the scanner for imaging.
Thus, the measured FDG-PET signal largely reflects the integral of neural activity during the uptake and positioning procedure, and not cognitive activity during the scan (Aiello et al., 2015; Villien et al., 2014) . Given that the BOLD-fMRI signal indexes recent neural activity designs that are capable of yielding sufficient signal to noise in both FDG functional PET (fPET) and BOLD-fMRI data sets when acquired using simultaneous experimental protocols. Recent preliminary results indicate significant neural activity can be simultaneously identified in both imaging modalities (see Figure 2) , with a temporal resolution of around 1 min for fPET and 2 s for fMRI .
| MR-PET receptor imaging
Exogenous and endogenous stimuli, including behaviourally relevant stimuli, pharmacological challenges and mood changes, evoke widespread changes in the neurotransmitter system of the brain. These changes in neurotransmission are important for understanding neural function in health and disease. For example, dynamic changes in the dopaminergic system are known to contribute to wide range behaviours including affect, decision-making and inhibitory control (Cools, Nakamura, & Daw, 2011) . Dynamic changes in neurotransmission are also known to contribute to CBV and BOLD changes (e.g., dopamine, Mandeville et al., 2013; GABA, Muthukumaraswamy, Evans, Edden, Wise, & Singh, 2012) . However, it has proved challenging to clarify the contributions of specific neurotransmitter systems to dynamic changes in the BOLD response. Simultaneous MR-PET offers the ability to concurrently measure changes in neuroreceptor occupancy and haemodynamic parameters, and thus disentangle the neurotransmitter contributions to the BOLD response. Hashimoto et al. (2014) [3-H]THK5117 Lemoine et al. (2015) [18-F]THK5351 Ng et al. (2017) [18-F]AV1451 (flortaucipir) Okamura et al. (2013) [18-F]T807 Chien et al. (2013) Efforts to understand the dynamic contributions of neurotransmitter systems on the fMRI response using simultaneous MR-PET has been led by the MGH group (e.g., Sander et al., 2013 Sander et al., , 2017 Sander, Hooker, Catana, Rosen, & Mandeville, 2016) . The TRIMAGE project is an initiative to develop simultaneous trimodal neuroimaging for biomarker discovery. Biomarker discovery projects have been largely focused towards schizophrenia, since putative schizophrenia biomarkers have been developed using each technology independently, without showing sufficient specificity to be diagnostic. Using the TRIMAGE trimodal system, Shah et al. (2017) examined the relationship between BOLD-fMRI activity in the default mode network to FDG-PET uptake in the network and resting-state EEG. BOLD-fMRI activity in the default mode network was positively related to FDG uptake in the network, but neither BOLD nor FDG was related to EEG connectivity across frequency bands (δ, θ, α, β1 -4). BOLD, FDG, EEG and DWI of the default mode were also not related to magnetic resonance spectroscopy measures of glutamate or GABA in the posterior component of the network (precuneus/posterior cingulate). Overall, these results are consistent with results obtained previously (e.g., Aiello et al., 2015; Riedl et al., 2014; Savio et al., 2017) showing that the BOLD-fMRI response is closely related to metabolic activity as measured by FDG-PET. While BOLD-fMRI activity within the default mode network was not related to EEG oscillatory activity, BOLD-fMRI connectivity between the default mode and sensorimotor network was related to EEG activity (δ, θ, α, β − 1), suggesting that the EEG measures were more sensitive to between network connectivity than within network connectivity.
In a proof-of-concept study, Del Guerra et al. (2018) used the TRIMAGE trimodal system to examine BOLD-fMRI, EEG (specifically, event-related potentials, ERPs) and glutamate receptor PET ([11-C] ABP688) in one healthy person and one person with schizophrenia. A mismatch negativity (MMN) task was used, as the EEG signature of MMN is a putative biomarker for schizophrenia (Michie, 2001 ). The person with schizophrenia showed reduced MMN amplitude, reduced BOLD-fMRI connectivity in the auditory network and reduced [11-C] ABP688 uptake relative to the healthy control. While these results are only preliminary, they are important for a number of reasons. Firstly, FIGURE 2 Simultaneous BOLD-fMRI/FDG-fPET activation using a checkboard visual stimulation in a single subject (adapted from Li et al., 2018) . Consistent with the results of (Wehrl et al., 2013) in the rat, the results from the two modalities are comparable, but with more focused activity in the FDG-fPET than BOLD-fMRI data [Color figure can be viewed at wileyonlinelibrary.com] they demonstrate that high-quality data can be obtained when acquiring all three modalities simultaneously, which is important given that each modality could introduce measurements errors and signal noise in the other measurements. Secondly, the results demonstrate the potential of the trimodal neuroimaging system to acquire comprehensive data sets that may aid in the early diagnosis of complex and multifactorial psychiatric illnesses including schizophrenia.
Trimodal neuroimaging is also possible on commercially available simultaneous MR-PET scanners. Golkowski et al. (2017) acquired BOLD-fMRI, FDG-PET and EEG in people with disorders of consciousness (minimally conscious/comatose). They found that (Ge et al., 1994; Woods, Mazziotta, & Cherry, 1993) . The full potential of simultaneously acquired MR-PET images will only be realised when simultaneous dynamic imaging with the two modalities is practicable, for example, tissue perfusion with MRI and tracer uptake with PET.
| Brain tumours
MRI is very sensitive to the presence of brain tumours but has limited specificity in differentiating high and low-grade gliomas, and in distinguishing recurrent disease from treatment-induced necrosis. Early work using [18-F]FDG showed some increase in specificity with the addition of PET information, but was limited by the very high background uptake of FDG in the brain and the relatively low uptake in some tumours, notably small metastases [reviewed in (Wong, van der Westhuizen, & Coleman, 2002) ]. This led to the development of more specific tracers for brain tumour imaging, such as [11-C] methionine ( 
| Epilepsy
Epilepsy is a very common condition in the community, with a life- radiotracer uptake at the site of the lesion. Co-registration with MRI, which is more readily achieved in a hybrid scanner, facilitates accurate lesion localisation, and surgical removal when appropriate (Kumar & Chugani, 2017) . Even if radiotracer administration around the time of seizure is not feasible, metabolic abnormalities (often hypometabolism) may be seen at the site of the epileptogenic lesion for scans acquired interictally. With the development of electrophysiological equipment (such as EEG) that can be used while the patient is in an MRI scanner, the possibility of adding simultaneous electrophysiological data to the metabolic information from PET and the high-resolution structural imaging of MRI has been realised (Grouiller et al., 2015) .
| Stroke
Stroke is a major cause of morbidity and mortality, but it is known that in some cases early treatment, involving thrombolysis and or clot retrieval, can lead to excellent recovery. Diffusion weighted MRI is highly sensitive to acute cerebral infarction and appears to be a reli- impaired, and there is markedly reduced uptake of the precursor molecule dopamine (and its molecular analogues) in specific brain sub-cortical nuclei (Booth et al., 2015) . patients with mild cognitive impairment concluded that more evidence was needed to establish its value in predicting progression to Alzheimer disease (Martínez et al., 2017) . Recent work has also suggested that tracers that demonstrate tau protein deposition may be more sensitive and specific in the diagnosis of dementias (Bejanin et al., 2017) . In a recent report by Mattsson et al., AV1451 PET was claimed to be superior to CSF tau protein measurements in the diagnosis of established Alzheimer's dementia, though not in the early clinical phase of the disease (Mattsson et al., 2018) . Currently, the main potential benefits to patients from the increasing use of amyloid and tau radiotracers are likely to be more accurate diagnoses, access to support and counselling services, and prognostication, rather than changes in outcome, as there are few if any effective treatments for these insidious conditions. 
| CONCLUSIONS
